{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:18:06Z","timestamp":1759033086527},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Natural Science Foundation of Ningxia","award":["NZ14131"],"award-info":[{"award-number":["NZ14131"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Inf."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s40708-015-0028-9","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T06:03:07Z","timestamp":1452232987000},"page":"29-37","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Quantitative multimodal multiparametric imaging in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"3","author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[]},{"given":"Xueqi","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"issue":"3","key":"28_CR1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","author":"Alzheimer\u2019s Association","year":"2015","unstructured":"Alzheimer\u2019s Association (2015) 2015 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 11(3):332\u2013384","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"28_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9(1):119\u2013128","journal-title":"Lancet Neurol"},{"issue":"5","key":"28_CR3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1532-5415.2011.03365.x","volume":"59","author":"H Brodaty","year":"2011","unstructured":"Brodaty H, Breteler MM, Dekosky ST, Dorenlot P, Fratiglioni L, Hock C et al (2011) The world of dementia beyond 2020. J Am Geriatr Soc 59(5):923\u2013927","journal-title":"J Am Geriatr Soc"},{"key":"28_CR4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS et al (2013) Tracking pathophysiological progresses in Alzheimer\u2019s Disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207\u2013216","journal-title":"Lancet Neurol"},{"key":"28_CR5","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G et al (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain 133:3336\u20133348","journal-title":"Brain"},{"issue":"5","key":"28_CR6","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","volume":"9","author":"MW Weiner","year":"2013","unstructured":"Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC et al (2013) The Alzheimer\u2019s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimer\u2019s Dement 9(5):e111\u2013e194","journal-title":"Alzheimer\u2019s Dement"},{"key":"28_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40708-015-0019-x","volume":"2","author":"S Liu","year":"2015","unstructured":"Liu S, Cai W, Liu S, Zhang F, Fulham M, Feng D et al (2015) Multimodal neuroimaging computing: a review of applications in neuropsychiatric disorders. Brain Inform 2:167\u2013180","journal-title":"Brain Inform"},{"issue":"7","key":"28_CR8","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cercor\/bhh200","volume":"15","author":"JP Lerch","year":"2005","unstructured":"Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC (2005) Focal decline of cortical thickness in Alzheimer\u2019s disease identified by computational neuroanatomy. Cereb Cortex 15(7):995\u20131001","journal-title":"Cereb Cortex"},{"issue":"2","key":"28_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6(2):67\u201377","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"28_CR10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","volume":"9","author":"H Hampel","year":"2010","unstructured":"Hampel H, Frank R, Broich K, Teipel SJ, Katz RG, Hardy J et al (2010) Biomarkers for Alzheimer\u2019s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9(7):560\u2013574","journal-title":"Nat Rev Drug Discov"},{"key":"28_CR11","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","volume":"47","author":"Y Stern","year":"2009","unstructured":"Stern Y (2009) Cognitive reserve. Neuropsychologia 47:2015\u20132028","journal-title":"Neuropsychologia"},{"issue":"11","key":"28_CR12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y (2012) Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol 11(11):1006\u20131012","journal-title":"Lancet Neurol"},{"issue":"8","key":"28_CR13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.euroneuro.2010.03.008","volume":"20","author":"MP Heuvel van den","year":"2010","unstructured":"van den Heuvel MP, Hulshoff Pol HE (2010) Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 20(8):519\u2013534","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"28_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-141824","volume":"44","author":"M Bozzali","year":"2015","unstructured":"Bozzali M, Dowling C, Serra L, Span\u00f2 B, Torso M, Marra C et al (2015) The impact of cognitive reserve on brain functional connectivity in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 44(1):243\u2013250","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"28_CR15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1148\/radiol.2343040197","volume":"234","author":"NA Johnson","year":"2005","unstructured":"Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ et al (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234(3):851\u2013859","journal-title":"Radiology"},{"issue":"1","key":"28_CR16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00234-012-1077-x","volume":"55","author":"SM Kim","year":"2013","unstructured":"Kim SM, Kim MJ, Rhee HY, Ryu CW, Kim EJ, Petersen ET et al (2013) Regional cerebral perfusion in patients with Alzheimer\u2019s disease and mild cognitive impairment: effect of APOE Epsilon4 allele. Neuroradiology 55(1):25\u201334","journal-title":"Neuroradiology"},{"issue":"1","key":"28_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3233\/JAD-2012-111877","volume":"31","author":"HK Mak","year":"2012","unstructured":"Mak HK, Chan Q, Zhang Z, Petersen ET, Qiu D, Zhang L et al (2012) Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer\u2019s disease and cognitively normal elderly adults at 3-tesla. J Alzheimer\u2019s Dis 31(1):33\u201344","journal-title":"J Alzheimer\u2019s Dis"},{"key":"28_CR18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","volume":"66","author":"RC Petersen","year":"2009","unstructured":"Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ et al (2009) Mild cognitive impairment: ten years later. Arch Neurol 66:1447\u20131455","journal-title":"Arch Neurol"},{"key":"28_CR19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Bar-berger-Gateau P et al (2010) Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol 9:1118\u20131127","journal-title":"Lancet Neurol"},{"issue":"1","key":"28_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1148\/radiol.12120928","volume":"267","author":"MA Binnewijzend","year":"2013","unstructured":"Binnewijzend MA, Kuijer JP, Benedictus MR, van der Flier WM, Wink AM, Wattjes MP et al (2013) Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology 267(1):221\u2013230","journal-title":"Radiology"},{"issue":"2","key":"28_CR21","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s00330-014-3172-3","volume":"24","author":"MA Binnewijzend","year":"2014","unstructured":"Binnewijzend MA, Kuijer JP, van der Flier WM, Benedictus MR, M\u00f6ller CM, Pijnenburg YA et al (2014) Distinct perfusion patterns in Alzheimer\u2019s disease, frontotemporal dementia and dementia with Lewy bodies. Eur Radiol 24(2):2326\u20132333","journal-title":"Eur Radiol"},{"issue":"10","key":"28_CR22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.mri.2014.07.003","volume":"32","author":"X Chen","year":"2014","unstructured":"Chen X, Huddleston DE, Langley J, Ahn S, Barnum CJ, Factor SA et al (2014) Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magn Reson Imaging 32(10):1301\u20131306","journal-title":"Magn Reson Imaging"},{"issue":"7","key":"28_CR23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nrn2420","volume":"9","author":"J G\u00f6tz","year":"2008","unstructured":"G\u00f6tz J, Ittner LM (2008) Animal models of Alzheimer\u2019s disease and frontotemporal dementia. Nat Rev Neurosci 9(7):532\u2013544","journal-title":"Nat Rev Neurosci"},{"key":"28_CR24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jmri.20675","volume":"24","author":"N Braakman","year":"2006","unstructured":"Braakman N, Matysik J, Van Duinen SG, Verbeek F, Schliebs R, De Groot HJM et al (2006) Longitudinal assessment of Alzheimer\u2019s beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 24:530\u2013536","journal-title":"J Magn Reson Imaging"},{"key":"28_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1148\/radiol.10100495","volume":"257","author":"C Langkammer","year":"2010","unstructured":"Langkammer C, Krebs N, Goessler W, Scheurer E, Ebner F, Yen K et al (2010) Quantitative MRI of brain iron: a postmortem validation study. Radiology 257:455\u2013462","journal-title":"Radiology"},{"key":"28_CR26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.neuroimage.2012.05.049","volume":"62","author":"C Langkammer","year":"2012","unstructured":"Langkammer C, Schweser F, Krebs N, Deistung A, Goessler W, Scheurer E et al (2012) Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 62:1593\u20131599","journal-title":"Neuroimage"},{"key":"28_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuroimage.2013.02.071","volume":"76","author":"NG Spencer","year":"2013","unstructured":"Spencer NG, Bridges LR, Elderfield K, Amir K, Austen B, Howe FA (2013) Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain. Neuroimage 76:108\u2013115","journal-title":"Neuroimage"},{"key":"28_CR28","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/mrm.21951","volume":"61","author":"R Chamberlain","year":"2009","unstructured":"Chamberlain R, Reyes D, Curran GL, Marjanska M, Wengenack TM, Poduslo JF et al (2009) Comparison of amyloid plaque contrast generated by T2-weighted, T2*-weighted, and susceptibility-weighted imaging methods in transgenic mouse models of Alzheimer\u2019s disease. Magn Reson Med 61:1158\u20131164","journal-title":"Magn Reson Med"},{"key":"28_CR29","doi-asserted-by":"crossref","first-page":"10041","DOI":"10.1523\/JNEUROSCI.2588-05.2005","volume":"25","author":"CR Jack","year":"2005","unstructured":"Jack CR, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowsk BJ et al (2005) In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer\u2019s transgenic mice. J Neurosci 25:10041\u201310048","journal-title":"J Neurosci"},{"key":"28_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1379.006","volume":"1097","author":"H Benveniste","year":"2007","unstructured":"Benveniste H, Ma Y, Dhawan J, Gifford A, Smith SD, Feinstein I et al (2007) Anatomical and functional phenotyping of mice models of Alzheimer\u2019s disease by MR microscopy. Ann NY Acad Sci 1097:12\u201329","journal-title":"Ann NY Acad Sci"},{"key":"28_CR31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-121171","volume":"34","author":"LO Sillerud","year":"2013","unstructured":"Sillerud LO, Solberg NO, Chamberlain R, Heidrich JE, Brown DC, Brady CI et al (2013) SPION-enhanced magnetic resonance imaging of Alzheimer\u2019s plaques in A\u03b2PP\/PS-1 transgenic mouse brain. J Alzheimer\u2019s Dis 34:349\u2013365","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"1","key":"28_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/JAD-131031","volume":"40","author":"NO Solberg","year":"2014","unstructured":"Solberg NO, Chamberlain R, Vigil JR, Deck LM, Heidrich JE, Brown DC et al (2014) Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-\u03baB concomitantly lower Alzheimer\u2019s disease plaque formation and microglial activation in A\u03b2PP\/PS-1 transgenic mouse brain. J Alzheimer\u2019s Dis 40(1):191\u2013212","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"7\u20138","key":"28_CR33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/nbm.783","volume":"15","author":"PJ Basser","year":"2002","unstructured":"Basser PJ, Jones DK (2002) Diffusion-tensor MRI: theory, experimental design and data analysis\u2014a technical review. NMR Biomed 15(7\u20138):456\u2013467","journal-title":"NMR Biomed"},{"issue":"3","key":"28_CR34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mcna.2012.12.013","volume":"97","author":"SJ Teipel","year":"2013","unstructured":"Teipel SJ, Grothe M, Lista S, Toschi N, Garaci FG, Hampel H (2013) Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med Clin N Am 97(3):399\u2013424","journal-title":"Med Clin N Am"},{"key":"28_CR35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2013.04.010","volume":"56","author":"JJ Sabbagh","year":"2013","unstructured":"Sabbagh JJ, Kinney JW, Cummings JL (2013) Alzheimer\u2019s disease biomarkers: correspondence between human studies and animal models. Neurobiol Dis 56:116\u2013130","journal-title":"Neurobiol Dis"},{"issue":"Suppl 3","key":"28_CR36","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.3233\/JAD-2012-112118","volume":"31","author":"SJ Teipel","year":"2012","unstructured":"Teipel SJ, Wegrzyn M, Meindl T, Frisoni G, Bokde AL, Fellgiebel A et al (2012) Anatomical MRI and DTI in the diagnosis of Alzheimer\u2019s disease: a European multicenter study. J Alzheimer\u2019s Dis 31(Suppl 3):S33\u2013S47","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"36","key":"28_CR37","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.2174\/13816128113199990370","volume":"19","author":"S Lista","year":"2013","unstructured":"Lista S, Garaci FG, Toschi N, Hampel H (2013) Imaging epigenetics in Alzheimer\u2019s disease. Curr Pharm Des 19(36):6393\u20136415","journal-title":"Curr Pharm Des"},{"issue":"11","key":"28_CR38","doi-asserted-by":"crossref","first-page":"e49072","DOI":"10.1371\/journal.pone.0049072","volume":"7","author":"J Acosta-Cabronero","year":"2012","unstructured":"Acosta-Cabronero J, Alley S, Williams GB, Pengas G, Nestor PJ (2012) Diffusion tensor metrics as biomarkers in Alzheimer\u2019s disease. PLoS One 7(11):e49072","journal-title":"PLoS One"},{"issue":"2\u20133","key":"28_CR39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pscychresns.2011.12.003","volume":"203","author":"T Bruggen van","year":"2012","unstructured":"van Bruggen T, Stieltjes B, Thomann PA, Parzer P, Meinzer HP, Fritzsche KH (2012) Do Alzheimer-specific microstructural changes in mild cognitive impairment predict conversion? Psychiatry Res 203(2\u20133):184\u2013193","journal-title":"Psychiatry Res"},{"issue":"3","key":"28_CR40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3233\/JAD-2012-121603","volume":"33","author":"P Selnes","year":"2013","unstructured":"Selnes P, Aarsland D, Bjornerud A, Gjerstad L, Wallin A, Hessen E et al (2013) Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J Alzheimer\u2019s Dis 33(3):723\u2013736","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"28_CR41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuroimage.2005.02.034","volume":"26","author":"A Pfefferbaum","year":"2005","unstructured":"Pfefferbaum A, Adalsteinsson E, Sullivan EV (2005) Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage 26(3):891\u2013899","journal-title":"Neuroimage"},{"issue":"6","key":"28_CR42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.neubiorev.2006.06.002","volume":"30","author":"EV Sullivan","year":"2006","unstructured":"Sullivan EV, Pfefferbaum A (2006) Diffusion tensor imaging and aging. Neurosci Biobehav Rev 30(6):749\u2013761","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"28_CR43","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.neuroimage.2011.10.015","volume":"59","author":"CY Wee","year":"2012","unstructured":"Wee CY, Yap PT, Zhang D, Denny K, Browndyke JN, Potter GG et al (2012) Identification of MCI individuals using structural and functional connectivity networks. Neuroimage 59(3):2045\u20132056","journal-title":"Neuroimage"},{"key":"28_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuroimage.2015.02.023","volume":"111","author":"JA Wells","year":"2015","unstructured":"Wells JA, O\u2019Callaghan JM, Holmes HE, Powell NM, Johnson RA, Siow B et al (2015) In vivo imaging of tau pathology using multi-parametric quantitative MRI. Neuroimage 111:369\u2013378","journal-title":"Neuroimage"},{"key":"28_CR45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12659\/MSM.883757","volume":"19","author":"A Zimny","year":"2013","unstructured":"Zimny A, Bladowska J, Neska M, Petryszyn K, Guzi\u0144ski M, Szewczyk P et al (2013) Quantitative MR evaluation of atrophy, as well as perfusion and diffusion alterations within hippocampi in patients with Alzheimer\u2019s disease and mild cognitive impairment. Med Sci Monit 19:86\u201394","journal-title":"Med Sci Monit"},{"issue":"19","key":"28_CR46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2010.06.002","volume":"31","author":"S Lancelot","year":"2010","unstructured":"Lancelot S, Zimmer L (2010) Small-animal positron emission tomography as a tool for neuropharmacology. Trends Pharmacol Sci 31(19):411\u2013417","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"28_CR47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/cns.12009","volume":"18","author":"N Aznavour","year":"2012","unstructured":"Aznavour N, Cendres-Bozzi C, Lemoine L, Buda C, Sastre JP, Mincheva Z et al (2012) MPTP animal model of Parkinsonism: dopamine cell death or only tyrosine hydroxylase impairment?\u2014A study using PET imaging, autoradiography and immunohistochemistry in the cat. CNS Neurosci Ther 18(11):934\u2013941","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"28_CR48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroimage.2011.12.037","volume":"61","author":"L Zimmer","year":"2012","unstructured":"Zimmer L, Luxen A (2012) PET radiotracers for molecular imaging in the brain: past, present and future. Neuroimage 61(2):363\u2013370","journal-title":"Neuroimage"},{"issue":"4","key":"28_CR49","doi-asserted-by":"crossref","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson KA, Fox NC, Sperling RA, Klunk WE (2012) Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med 2(4):a006213","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"28_CR50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1474-4422(11)70123-5","volume":"10","author":"K Herholz","year":"2011","unstructured":"Herholz K, Ebmeier K (2011) Clinical amyloid imaging in Alzheimer\u2019s disease. Lancet Neurol 10(7):667\u2013670","journal-title":"Lancet Neurol"},{"issue":"4","key":"28_CR51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32(4):486\u2013510","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"28_CR52","doi-asserted-by":"crossref","first-page":"e67163","DOI":"10.1371\/journal.pone.0067163","volume":"8","author":"F Schraml","year":"2013","unstructured":"Schraml F, Chen K, Ayutyanont N, Auttawut R, Langbaum JB, Lee W et al (2013) Association between an Alzheimer\u2019s disease-related index and gene dose. PLoS One 8(6):e67163","journal-title":"PLoS One"},{"key":"28_CR53","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroimage.2012.09.065","volume":"65","author":"KR Gray","year":"2013","unstructured":"Gray KR, Aljabar P, Heckemann RA, Hammers A, Rueckert D (2013) Alzheimer\u2019s Disease Neuroimaging Initiative. Random forest-based similarity measures for multi-modal classification of Alzheimer\u2019s disease. Neuroimage 65:167\u2013175","journal-title":"Neuroimage"},{"issue":"2","key":"28_CR54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.12120010","volume":"266","author":"JL Shaffer","year":"2013","unstructured":"Shaffer JL, Petrella JR, Sheldon FC, Choudhury KR, Calhoun VD, Edward Coleman R et al (2013) Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 266(2):583\u2013591","journal-title":"Radiology"},{"key":"28_CR55","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jalz.2013.11.009","volume":"10","author":"JJ Gomar","year":"2014","unstructured":"Gomar JJ, Conejero-Goldberg C, Davies P, Goldberg TE, Alzheimer\u2019s Disease Neuroimaging Initiative (2014) Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data. Alzheimer\u2019s Dement 10:704\u2013712","journal-title":"Alzheimer\u2019s Dement"},{"key":"28_CR56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2013.06.018","volume":"35","author":"PT Trzepacz","year":"2014","unstructured":"Trzepacz PT, Yu P, Sun J, Schuh K, Case M, Witte MM et al (2014) Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer\u2019s dementia. Neurobiol Aging 35:143\u2013151","journal-title":"Neurobiol Aging"},{"key":"28_CR57","first-page":"260","volume":"6","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Huang H, Shen D (2014) Alzheimer\u2019s Disease Neuroimaging Initiative. Integrative analysis of multi-dimensional imaging genomics data for Alzheimer\u2019s disease prediction. Front Aging Neurosci 6:260","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"28_CR58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova I, Karran E, De Strooper B (2012) The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat Neurosci 15(3):349\u2013357","journal-title":"Nat Neurosci"},{"issue":"6880","key":"28_CR59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416(6880):535\u2013539","journal-title":"Nature"},{"issue":"5825","key":"28_CR60","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer\u2019s disease mouse model. Science 316(5825):750\u2013754","journal-title":"Science"},{"issue":"6","key":"28_CR61","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol 13(6):614\u2013629","journal-title":"Lancet Neurol"},{"issue":"3","key":"28_CR62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","volume":"7","author":"CR Jack Jr","year":"2011","unstructured":"Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC et al (2011) Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association Workgroups on Diagnostic Guidelines for Alzheimer\u2019s Disease. Alzheimer\u2019s Dement 7(3):257\u2013262","journal-title":"Alzheimer\u2019s Dement"},{"issue":"5580","key":"28_CR63","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"2","key":"28_CR64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2967\/jnumed.108.056499","volume":"50","author":"N Tolboom","year":"2009","unstructured":"Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G, Windhorst AD et al (2009) Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J Nucl Med 50(2):191\u2013197","journal-title":"J Nucl Med"},{"issue":"19","key":"28_CR65","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000260969.94695.56","volume":"68","author":"NM Kemppainen","year":"2007","unstructured":"Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A et al (2007) PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology 68(19):1603\u20131606","journal-title":"Neurology"},{"issue":"9","key":"28_CR66","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/jnnp-2012-302548","volume":"83","author":"DA Wolk","year":"2012","unstructured":"Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE (2012) Amyloid imaging in Alzheimer\u2019s disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. J Neurol Neurosurg Psychiatry 83(9):923\u2013926","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"28_CR67","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(04)00853-1","volume":"3","author":"A Nordberg","year":"2004","unstructured":"Nordberg A (2004) PET imaging of amyloid in Alzheimer\u2019s disease. Lancet Neurol 3(9):519\u2013527","journal-title":"Lancet Neurol"},{"issue":"13","key":"28_CR68","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE (2003) Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem 46(13):2740\u20132754","journal-title":"J Med Chem"},{"issue":"24","key":"28_CR69","doi-asserted-by":"crossref","first-page":"RC189","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","volume":"21","author":"ED Agdeppa","year":"2001","unstructured":"Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A et al (2001) Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer\u2019s disease. J Neurosci 21(24):RC189","journal-title":"J Neurosci"},{"issue":"6","key":"28_CR70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0969-8051(03)00049-0","volume":"30","author":"M Ono","year":"2003","unstructured":"Ono M, Wilson A, Nobrega J, Westaway D, Verhoeff P, Zhuang ZP et al (2003) 11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer\u2019s disease. Nucl Med Biol 30(6):565\u2013571","journal-title":"Nucl Med Biol"},{"issue":"2","key":"28_CR71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"CC Rowe","year":"2008","unstructured":"Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O\u2019Keefe G et al (2008) Imaging of amyloid beta in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol 7(2):129\u2013135","journal-title":"Lancet Neurol"},{"issue":"11","key":"28_CR72","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","volume":"50","author":"SR Choi","year":"2009","unstructured":"Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F et al (2009) Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med 50(11):1887\u20131894","journal-title":"J Nucl Med"},{"issue":"3","key":"28_CR73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","volume":"68","author":"R Vandenberghe","year":"2010","unstructured":"Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E et al (2010) 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68(3):319\u2013329","journal-title":"Ann Neurol"},{"issue":"8","key":"28_CR74","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2967\/jnumed.109.063305","volume":"50","author":"N Nelissen","year":"2009","unstructured":"Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M et al (2009) Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med 50(8):1251\u20131259","journal-title":"J Nucl Med"},{"issue":"11","key":"28_CR75","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00259-009-1182-1","volume":"36","author":"S Nyberg","year":"2009","unstructured":"Nyberg S, J\u00f6nhagen ME, Csel\u00e9nyi Z, Halldin C, Julin P, Olsson H et al (2009) Detection of amyloid in Alzheimer\u2019s disease with positron emission tomography using [11C]AZD2184. Eur J Nucl Med Mol Imaging 36(11):1859\u20131863","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"28_CR76","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.111.094029","volume":"53","author":"Z Csel\u00e9nyi","year":"2012","unstructured":"Csel\u00e9nyi Z, J\u00f6nhagen ME, Forsberg A, Halldin C, Julin P, Schou M et al (2012) Clinical validation of 18F-AZD4694, an amyloid-beta-specific PET radioligand. J Nucl Med 53(3):415\u2013424","journal-title":"J Nucl Med"},{"issue":"9","key":"28_CR77","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.nucmedbio.2015.05.001","volume":"42","author":"M Shidahara","year":"2015","unstructured":"Shidahara M, Watabe H, Tashiro M, Okamura N, Furumoto S et al (2015) Quantitative kinetic analysis of PET amyloid imaging agents [11C]BF227 and [18F]FACT in human brain. Nucl Med Biol 42(9):734\u2013744","journal-title":"Nucl Med Biol"},{"issue":"3","key":"28_CR78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/mp.2013.19","volume":"19","author":"VK Ramanan","year":"2014","unstructured":"Ramanan VK, Risacher SL, Nho K, Kim S, Swaminathan S, Shen L et al (2014) APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study. Mol Psychiatry 19(3):351\u2013357","journal-title":"Mol Psychiatry"},{"issue":"1","key":"28_CR79","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jalz.2013.01.007","volume":"10","author":"S Swaminathan","year":"2014","unstructured":"Swaminathan S, Risacher SL, Yoder KK, West JD, Shen L, Kim S et al (2014) Association of plasma and cortical amyloid beta is modulated by APOE epsilon4 status. Alzheimer\u2019s Dement 10(1):e9\u2013e18","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"28_CR80","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neurobiolaging.2013.08.032","volume":"35","author":"TJ Hohman","year":"2014","unstructured":"Hohman TJ, Koran ME, Thornton-Wells TA, Alzheimer\u2019s Neuroimaging Initiative (2014) Interactions between GSK3beta and amyloid genes explain variance in amyloid burden. Neurobiol Aging 35(3):460\u2013465","journal-title":"Neurobiol Aging"},{"issue":"3","key":"28_CR81","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP et al (2004) Imaging brain amyloid in Alzheimer\u2019 disease with Pittsburgh compound-B. Ann Neurol 55(3):306\u2013319","journal-title":"Ann Neurol"},{"issue":"3","key":"28_CR82","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA et al (2011) Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 305(3):275\u2013283","journal-title":"JAMA"},{"issue":"1","key":"28_CR83","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WAD.0b013e31821300bc","volume":"26","author":"SR Choi","year":"2012","unstructured":"Choi SR, Schneider JA, Bennett DA, Beach TG, Bedell BJ, Zehntner SP et al (2012) Correlation of amyloid PET ligand florbetapir F18 binding with Abeta aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord 26(1):8\u201316","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"28_CR84","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2967\/jnumed.108.060756","volume":"50","author":"M Koole","year":"2009","unstructured":"Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ et al (2009) Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med 50(5):818\u2013822","journal-title":"J Nucl Med"},{"issue":"5","key":"28_CR85","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K et al (2011) Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10(5):424\u2013435","journal-title":"Lancet Neurol"},{"issue":"11","key":"28_CR86","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","volume":"68","author":"AS Fleisher","year":"2011","unstructured":"Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N et al (2011) Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol 68(11):1404\u20131411","journal-title":"Arch Neurol"},{"issue":"7","key":"28_CR87","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s12149-015-0978-2","volume":"29","author":"C Namiki","year":"2015","unstructured":"Namiki C, Takita Y, Iwata A, Momose T, Senda M, Okubo Y et al (2015) Imaging characteristics and safety of florbetapir (18F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer\u2019s disease. Ann Nucl Med 29(7):570\u2013581","journal-title":"Ann Nucl Med"},{"issue":"5 Suppl","key":"28_CR88","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","volume":"9","author":"KA Johnson","year":"2013","unstructured":"Johnson KA, Sperling RA, Gidicsin C, Carmasin JS, Maye JE, Coleman RE et al (2013) Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer\u2019s disease dementia, mild cognitive impairment, and normal aging. Alzheimer\u2019s Dement 9(5 Suppl):S72\u2013S83","journal-title":"Alzheimer\u2019s Dement"},{"issue":"9","key":"28_CR89","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00259-015-3067-9","volume":"42","author":"P Payoux","year":"2015","unstructured":"Payoux P, Delrieu J, Gallini A, Adel D, Salabert AS, Hitzel A et al (2015) Cognitive and functional patterns of nondemented subjects with equivocal visual amyloid PET findings. Eur J Nucl Med Mol Imaging 42(9):1459\u20131468","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"28_CR90","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00259-013-2478-8","volume":"40","author":"A Bruck","year":"2013","unstructured":"Bruck A, Virta JR, Koivunen J, Koikkalainen J, Scheinin NM, Helenius H et al (2013) [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment. Eur J Nucl Med Mol Imaging 40(10):1567\u20131572","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"28_CR91","doi-asserted-by":"crossref","first-page":"e66877","DOI":"10.1371\/journal.pone.0066877","volume":"8","author":"S Hatashita","year":"2013","unstructured":"Hatashita S, Yamasaki H (2013) Diagnosed mild cognitive impairment due to Alzheimer\u2019s disease with PET biomarkers of beta amyloid and neuronal dysfunction. PLoS One 8(6):e66877","journal-title":"PLoS One"},{"key":"28_CR92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-015-0090-6","volume":"5","author":"BH Yousefi","year":"2015","unstructured":"Yousefi BH, von Reutern B, Scher\u00fcbl D, Manook A, Schwaiger M, Grimmer T et al (2015) FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice. EJNMMI Res 5:20","journal-title":"EJNMMI Res"},{"issue":"5","key":"28_CR93","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-4159.2008.05861.x","volume":"108","author":"AE Johnson","year":"2009","unstructured":"Johnson AE, Jeppsson F, Sandell J, Wensbo D, Neelissen JA, Jur\u00e9us A et al (2009) AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. J Neurochem 108(5):1177\u20131186","journal-title":"J Neurochem"},{"issue":"6","key":"28_CR94","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.113.133793","volume":"55","author":"H Ito","year":"2014","unstructured":"Ito H, Shimada H, Shinotoh H, Takano H, Sasaki T, Nogami T et al (2014) Quantitative analysis of amyloid deposition in Alzheimer disease using PET and the radiotracer 11C-AZD2184. J Nucl Med 55(6):932\u2013938","journal-title":"J Nucl Med"},{"issue":"12","key":"28_CR95","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.2967\/jnumed.112.105346","volume":"53","author":"C Catana","year":"2012","unstructured":"Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET\/MRI for neurologic applications. J Nucl Med 53(12):1916\u20131925","journal-title":"J Nucl Med"},{"key":"28_CR96","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.neuroimage.2011.01.008","volume":"55","author":"D Zhang","year":"2011","unstructured":"Zhang D, Wang Y, Zhou L, Yuan H, Shen D (2011) Multimodal classification of Alzheimer\u2019s disease and mild cognitive impairment. Neuroimage 55:856\u2013867","journal-title":"Neuroimage"},{"key":"28_CR97","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3174\/ajnr.A1900","volume":"31","author":"S Bisdas","year":"2010","unstructured":"Bisdas S, Nagele T, Schlemmer P, Boss A, Claussen C, Pichler B et al (2010) Switching on the lights for real-time multimodality tumor neuroimaging: the integrated positron emission tomography\/MR imaging system. Am J Neuroradiol 31:610\u2013614","journal-title":"Am J Neuroradiol"},{"issue":"12","key":"28_CR98","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/nm.3734","volume":"20","author":"FC Maier","year":"2014","unstructured":"Maier FC, Wehrl HF, Schmid AM, Mannheim JG, Wiehr S, Lerdkrai C et al (2014) Longitudinal PET\u2013MRI reveals \u03b2-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion. Nat Med 20(12):1485\u20131492","journal-title":"Nat Med"},{"key":"28_CR99","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroimage.2012.12.014","volume":"70","author":"P Edison","year":"2013","unstructured":"Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A et al (2013) Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET. Neuroimage 70:423\u2013433","journal-title":"Neuroimage"},{"issue":"1","key":"28_CR100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jmri.24550","volume":"41","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Yu F, Duong TQ, Alzheimer\u2019s Disease Neuroimaging Initiative (2015) White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer\u2019s disease patients. J Magn Reson Imaging 41(1):102\u2013109","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"28_CR101","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/1567205012666150530202124","volume":"12","author":"CM Kim","year":"2015","unstructured":"Kim CM, Hwang J, Lee JM, Roh JH, Lee JH, Koh JY et al (2015) Amyloid beta-weighted cortical thickness: a new imaging biomarker in Alzheimer\u2019s disease. Curr Alzheimer Res 12(6):563\u2013571","journal-title":"Curr Alzheimer Res"},{"issue":"11","key":"28_CR102","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nbt899","volume":"21","author":"WR Zipfel","year":"2003","unstructured":"Zipfel WR, Williams RM, Webb WW (2003) Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol 21(11):1369\u20131377","journal-title":"Nat Biotechnol"},{"issue":"7","key":"28_CR103","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1194\/jlr.M003616","volume":"51","author":"RS Lim","year":"2010","unstructured":"Lim RS, Kratzer A, Barry NP, Miyazaki-Anzai S, Miyazaki M, Mantulin WW (2010) Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice. J Lipid Res 51(7):1729\u20131737","journal-title":"J Lipid Res"},{"issue":"3","key":"28_CR104","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00418-013-1161-2","volume":"141","author":"N Billecke","year":"2014","unstructured":"Billecke N, Rago G, Bosma M, Eijkel G, Gemmink A, Leproux P et al (2014) Chemical imaging of lipid droplets in muscle tissues using hyperspectral coherent Raman microscopy. Histochem Cell Biol 141(3):263\u2013273","journal-title":"Histochem Cell Biol"},{"issue":"7","key":"28_CR105","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/ten.tec.2013.0472","volume":"20","author":"YJ Lee","year":"2014","unstructured":"Lee YJ, Vega SL, Patel PJ, Aamer KA, Moghe PV, Cicerone MT (2014) Quantitative, label-free characterization of stem cell differentiation at the single-cell level by broadband coherent anti-Stokes Raman scattering microscopy. Tissue Eng C 20(7):562\u2013569","journal-title":"Tissue Eng C"},{"issue":"11","key":"28_CR106","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1194\/jlr.R008730","volume":"51","author":"TT Le","year":"2010","unstructured":"Le TT, Yue S, Cheng JX (2010) Shedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopy. J Lipid Res 51(11):3091\u20133102","journal-title":"J Lipid Res"},{"issue":"3","key":"28_CR107","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1523\/JNEUROSCI.21-03-00858.2001","volume":"21","author":"RH Christie","year":"2001","unstructured":"Christie RH, Bacskai BJ, Zipfel WR, Williams RM, Kajdasz ST, Webb WW et al (2001) Growth arrest of individual senile plaques in a model of Alzheimer\u2019s disease observed by in vivo multiphoton microscopy. J Neurosci 21(3):858\u2013864","journal-title":"J Neurosci"},{"issue":"5","key":"28_CR108","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1364\/OE.17.003679","volume":"17","author":"AC Kwan","year":"2009","unstructured":"Kwan AC, Duff K, Gouras GK, Webb WW (2009) Optical visualization of Alzheimer\u2019s pathology via multiphoton-excited intrinsic fluorescence and second harmonic generation. Opt Express 17(5):3679\u20133689","journal-title":"Opt Express"},{"issue":"5","key":"28_CR109","doi-asserted-by":"crossref","first-page":"56013","DOI":"10.1117\/1.JBO.20.5.056013","volume":"20","author":"JH Lee","year":"2015","unstructured":"Lee JH, Kim DH, Song WK, Oh MK, Ko DK (2015) Label-free imaging and quantitative chemical analysis of Alzheimer\u2019s disease brain samples with multimodal multiphoton nonlinear optical microspectroscopy. J Biomed Opt 20(5):56013","journal-title":"J Biomed Opt"},{"key":"28_CR110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fnagi.2014.00138","volume":"6","author":"N Braidy","year":"2014","unstructured":"Braidy N, Poljak A, Marjo C, Rutlidge H, Rich A, Jayasena T et al (2014) Metal and complementary molecular bioimaging in Alzheimer\u2019s disease. Front Aging Neurosci 6:138","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"28_CR111","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1039\/B916722F","volume":"2","author":"JS Becker","year":"2010","unstructured":"Becker JS, Matusch A, Palm C, Salber D, Morton KA, Becker JS (2010) Bioimaging of metals in brain tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and metallomics. Metallomics 2(2):104\u2013111","journal-title":"Metallomics"},{"key":"28_CR112","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroimage.2010.11.073","volume":"55","author":"AC Leskovjan","year":"2011","unstructured":"Leskovjan AC, Kretlow A, Lanzirotti A, Barrea R, Vogt S, Miller LM (2011) Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer\u2019s disease. Neuroimage 55:32\u201338","journal-title":"Neuroimage"},{"key":"28_CR113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.mad.2004.09.032","volume":"126","author":"TC Rohner","year":"2005","unstructured":"Rohner TC, Staab D, Stoeckli M (2005) MALDI mass spectrometric imaging of biological tissue sections. Mech Ageing Dev 126:177\u2013185","journal-title":"Mech Ageing Dev"},{"key":"28_CR114","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.bbamem.2007.05.026","volume":"1768","author":"H Komatsu","year":"2007","unstructured":"Komatsu H, Liu L, Murray IV, Axelsen PH (2007) A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy. Biochim Biophys Acta 1768:1913\u20131922","journal-title":"Biochim Biophys Acta"},{"key":"28_CR115","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jalz.2015.05.009","volume":"11","author":"AJ Saykin","year":"2015","unstructured":"Saykin AJ, Shen L, Yao X, Kim S, Nho K, Risacher SL et al (2015) Genetic studies of quantitative MCI and AD phenotypes in ADNI: progress, opportunities, and plans. Alzheimer\u2019s Dement 11:792\u2013814","journal-title":"Alzheimer\u2019s Dement"},{"key":"28_CR116","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S et al (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370:311\u2013321","journal-title":"N Engl J Med"},{"key":"28_CR117","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M et al (2014) Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 370:322\u2013333","journal-title":"N Engl J Med"},{"key":"28_CR118","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(10)70306-9","volume":"10","author":"WM Flier Van der","year":"2010","unstructured":"Van der Flier WM, Pijnenburg YA, Fox NC, Scheltens P (2010) Early-onset versus late-onset Alzheimer\u2019s disease: the case of the missing APOE \u03b54 allele. Lancet Neurol 10:280\u2013288","journal-title":"Lancet Neurol"}],"container-title":["Brain Informatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40708-015-0028-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40708-015-0028-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40708-015-0028-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T08:35:34Z","timestamp":1567499734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40708-015-0028-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["28"],"URL":"https:\/\/doi.org\/10.1007\/s40708-015-0028-9","relation":{},"ISSN":["2198-4018","2198-4026"],"issn-type":[{"value":"2198-4018","type":"print"},{"value":"2198-4026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,8]]}}}